The present invention provides compounds of formula I, 1 and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.

 
Web www.patentalert.com

< Protease inhibitors

< Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use

> Dibenzo chromene derivatives and their use as ERbeta selective ligands

> Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders

~ 00216